Emily Peterson Alva - Net Worth and Insider Trading

Emily Peterson Alva Net Worth

The estimated net worth of Emily Peterson Alva is at least $40,722 dollars as of 2024-04-28. Emily Peterson Alva is the Director of Alkermes PLC and owns about 1,650 shares of Alkermes PLC (ALKS) stock worth over $40,722. Details can be seen in Emily Peterson Alva's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Emily Peterson Alva has not made any transactions after 2021-08-23 and currently still holds the listed stock(s).

Transaction Summary of Emily Peterson Alva

To

Emily Peterson Alva Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Emily Peterson Alva owns 2 companies in total, including Amneal Pharmaceuticals Inc (AMRX) , and Alkermes PLC (ALKS) .

Click here to see the complete history of Emily Peterson Alva’s form 4 insider trades.

Insider Ownership Summary of Emily Peterson Alva

Ticker Comapny Transaction Date Type of Owner
AMRX Amneal Pharmaceuticals Inc 2018-05-04 director
ALKS Alkermes PLC 2021-08-23 director

Emily Peterson Alva Latest Holdings Summary

Emily Peterson Alva currently owns a total of 1 stock. Emily Peterson Alva owns 1,650 shares of Alkermes PLC (ALKS) as of August 23, 2021, with a value of $40,722.

Latest Holdings of Emily Peterson Alva

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALKS Alkermes PLC 2021-08-23 1,650 24.68 40,722

Holding Weightings of Emily Peterson Alva


Emily Peterson Alva Form 4 Trading Tracker

According to the SEC Form 4 filings, Emily Peterson Alva has made a total of 1 transactions in Alkermes PLC (ALKS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Alkermes PLC is the acquisition of 1,650 shares on August 23, 2021, which cost Emily Peterson Alva around $49,863.

Insider Trading History of Emily Peterson Alva

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Emily Peterson Alva Trading Performance

GuruFocus tracks the stock performance after each of Emily Peterson Alva's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Emily Peterson Alva is -24.39%. GuruFocus also compares Emily Peterson Alva's trading performance to market benchmark return within the same time period. The performance of stocks bought by Emily Peterson Alva within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Emily Peterson Alva's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Emily Peterson Alva

Average Return

-17.1%

Average return per transaction

Outperforming Transactions

0%

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.19 -24.39 -19.7 -17.1 -3.63
Relative Return to S&P 500(%) 6.87 -29.1 -14.03 -9.27 -3.14

Emily Peterson Alva Ownership Network

Ownership Network List of Emily Peterson Alva

No Data

Ownership Network Relation of Emily Peterson Alva


Emily Peterson Alva Owned Company Details

What does Amneal Pharmaceuticals Inc do?

Who are the key executives at Amneal Pharmaceuticals Inc?

Emily Peterson Alva is the director of Amneal Pharmaceuticals Inc. Other key executives at Amneal Pharmaceuticals Inc include Exec VP & Comm Optns Andrew S Boyer , 10 percent owner Tpg Gp A, Llc , and See Remarks Gustavo Pesquin .

Amneal Pharmaceuticals Inc (AMRX) Insider Trades Summary

Over the past 18 months, Emily Peterson Alva made no insider transaction in Amneal Pharmaceuticals Inc (AMRX). Other recent insider transactions involving Amneal Pharmaceuticals Inc (AMRX) include a net sale of 3,884,600 shares made by Tpg Gp A, Llc , and a net sale of 29,302 shares made by Andrew S Boyer .

In summary, during the past 3 months, insiders sold 0 shares of Amneal Pharmaceuticals Inc (AMRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,913,902 shares of Amneal Pharmaceuticals Inc (AMRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,913,902 shares.

Amneal Pharmaceuticals Inc (AMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amneal Pharmaceuticals Inc Insider Transactions

No Available Data

Emily Peterson Alva Mailing Address

Above is the net worth, insider trading, and ownership report for Emily Peterson Alva. You might contact Emily Peterson Alva via mailing address: C/o Amneal Pharmaceuticals Llc, 400 Crossing Boulevard, Bridgewater Nj 08807.

Discussions on Emily Peterson Alva

No discussions yet.